(DOCS) Doximity, Inc. Marketing Mix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(DOCS) Doximity, Inc. Complete Analysis Pack
Visual. Strategic. Downloadable.
This Doximity, Inc. 4P's Marketing Mix Analysis explains the company’s Product, Price, Place, and Promotion strategy and shows how these elements support positioning and growth; the page includes a real preview/sample of the report so you can inspect style and content before buying. Purchase the full version to receive the complete ready-to-use analysis.
Product
Cloud-based clinician platform
Doximity's cloud-based clinician platform gives U.S. doctors secure, always-on access to messaging, telehealth, and workflow tools, and it reaches over 80% of U.S. physicians. In FY2025, Doximity reported revenue of about $476 million, showing strong demand for its digital clinical network. The platform is built for daily use, so clinicians can move between patient care and professional tasks without leaving the system.
Peer networking tools
Peer networking tools let clinicians connect with peers and other healthcare professionals, which supports referrals, collaboration, and faster professional communication. Doximity said its network reached over 2.2 million U.S. healthcare professionals, including more than 80% of U.S. physicians, in fiscal 2025. That scale makes the physician community model a real product advantage.
Remote consultation tools
Doximity’s remote consultation tools let clinicians manage care without depending only on in-person visits, which fits the move to digital care. The platform says it reaches over 80% of U.S. physicians and more than 2 million medical professionals, so the feature has real scale. In fiscal 2025, Doximity reported $570.4 million in revenue, showing strong demand for these digital workflow tools.
Medical news and research access
Members can pull current medical news and research inside Doximity, so the product stays tied to daily clinical work and not just messaging. Doximity reported FY2025 revenue of $570.4 million, and that scale helps fund fresh content that keeps physicians returning for updates.
This access raises engagement because users check the platform for evidence, practice changes, and specialty news. The result is more frequent use, stronger retention, and a product that fits the workflow of a large physician network.
- FY2025 revenue: $570.4 million
- Keeps users on-platform longer
- Supports daily clinical check-ins
Pharma and healthcare organization solutions
Doximity’s pharma and healthcare organization solutions sell to drugmakers and health systems, using its clinician network to target workflows and digital engagement. In FY2025, Doximity reported $570.4 million in revenue, showing enterprise demand for its dual-sided platform. It can reach over 80% of U.S. physicians, which is the core product edge.
- Primary buyers: pharma and health systems
- FY2025 revenue: $570.4 million
- Reach: over 80% of U.S. physicians
Doximity's clinician network drives $570M in FY2025 revenue
Doximity's Product centers on a sticky clinician network built for daily work: secure messaging, telehealth, news, and peer tools. In FY2025, the platform reached over 2.2 million healthcare professionals and more than 80% of U.S. physicians, helping drive $570.4 million in revenue.
| Key product metric | FY2025 |
|---|---|
| Revenue | $570.4 million |
| Healthcare professional reach | 2.2 million+ |
| U.S. physician reach | 80%+ |
What is included in the product
Detailed Word Document
A concise, company-specific 4P’s analysis of Doximity, Inc.’s Product, Price, Place, and Promotion strategies for strategic benchmarking.
Editable Excel File
Condenses Doximity’s 4Ps into a quick, clear snapshot that makes strategy easy to review and discuss.
Reference Sources
Cites primary industry reports, gov datasets, and company filings to back Doximity market, pricing, and unit-economics assumptions for faster, defensible due diligence.
Place
U.S.-only market
Doximity’s market is U.S.-only, serving more than 80% of U.S. physicians and over 50% of nurse practitioners and physician assistants, so its reach is tightly tied to domestic clinical workflows and HIPAA rules. In fiscal 2025, Doximity reported $570.7 million in revenue, showing that its U.S.-focused distribution can scale without relying on global retail channels.
Cloud distribution
Doximity’s cloud distribution keeps the platform online, so members access it without local hardware or a physical network. The model scales fast: Doximity served more than 2 million members and reported FY2025 revenue of about $570 million, showing how cloud delivery supports broad, low-friction reach. It also cuts distribution overhead and helps features roll out quickly across the U.S. healthcare network.
Web and mobile access
Doximity has no store footprint; it reaches clinicians through web and mobile channels, so the service is available where they work and travel. Its network includes over 2 million U.S. healthcare professionals, which supports fast, targeted access across devices. That digital-first setup makes it easier for clinicians to use the platform between patient visits and on the move.
Direct enterprise sales
Doximity, Inc. sells to pharmaceutical companies and healthcare organizations through direct business-to-business sales, a standard route for enterprise software and media. This lets it tailor products, pricing, and ad packages to each buyer; in FY2025, Doximity reported $570.4 million in revenue, showing the scale that direct enterprise deals can support.
- Direct B2B sales fit enterprise buyers
- Supports tailored offers and contracts
- FY2025 revenue: $570.4 million
San Francisco headquarters
Doximity, Inc. is headquartered in San Francisco, California, and that office is its main base for corporate, product, and sales work. In FY2025, Doximity reported $570.4 million in revenue, underscoring the scale managed from this hub. The location keeps leadership, product teams, and go-to-market operations close together.
- Main base in San Francisco
- Supports corporate, product, sales
- FY2025 revenue: $570.4 million
Doximity Scales Digital Distribution to Reach 80% of U.S. Physicians
Doximity’s place strategy is fully digital and U.S.-only, with no retail footprint; clinicians access it on web and mobile where they work. The platform reached more than 2 million members and more than 80% of U.S. physicians, so distribution is broad without physical channels.
Direct B2B sales to pharma and healthcare buyers keeps delivery targeted and contract-based. In FY2025, Doximity generated $570.4 million in revenue, showing that this channel scales well.
| Place factor | FY2025 data |
|---|---|
| Reach | 2M+ members |
| Physician coverage | 80%+ of U.S. physicians |
| Revenue | $570.4M |
| Footprint | No physical stores |
Full Version Awaits
Doximity, Inc. Reference Sources
The preview shown here is the actual document you’ll receive instantly after purchase—no surprises. This Doximity, Inc. 4P's Marketing Mix Analysis is the exact, fully complete file you’ll download: product positioning, pricing strategy, distribution channels, and promotional tactics tailored to Doximity’s market dynamics. Ready to use upon checkout.
Promotion
Free clinician membership
Doximity gives clinicians free membership, which cuts the sign-up barrier to zero and speeds adoption. Its network now reaches over 80% of U.S. physicians, so each new free user makes the platform more useful for enterprise customers. That network effect helped Doximity generate fiscal 2025 revenue of about $570 million.
Physician network reach
Doximity says its network reaches more than 80% of U.S. physicians and over 2 million healthcare professionals. That scale makes the brand highly visible in healthcare and gives advertisers a single place to reach clinicians. In FY2025, revenue reached about $570 million, showing how that audience supports partner demand.
Targeted digital campaigns
Doximity’s targeted digital campaigns are a core enterprise tool for pharmaceutical advertisers, using clinician data to deliver relevant messages and content. In fiscal 2025, Doximity reported $475.6 million in revenue, with advertising and marketing solutions driving a large share of the model. Its network reached more than 80% of U.S. physicians, giving pharma brands scale plus precision.
Sales-led enterprise outreach
Doximity uses direct sales to reach healthcare organizations and life sciences buyers, a fit for high-ticket B2B software that needs demos, account support, and contract work. The channel matches its scale: in fiscal 2025, Doximity reported about $570 million in revenue, showing enterprise outreach is tied to a large paid customer base. It is a sales-heavy motion, not a self-serve one.
Direct demos drive adoption
Teams manage enterprise accounts
Sales closes long healthcare deals
Healthcare content and PR
Doximity uses healthcare content and PR to keep its brand in front of clinicians and enterprise buyers, and that matters in a FY2025 business that generated $570.4 million in revenue. Thought leadership, earned media, and industry commentary help frame Doximity as a healthcare technology platform, not just a networking tool. That visibility supports trust, which is key when the company serves a large clinician base and sells into health systems.
- FY2025 revenue: $570.4 million
- Content and PR build clinician trust
Doximity’s Reach Drives $570M in Revenue
Doximity’s promotion mix leans on targeted digital ads, direct sales, and content that reaches over 80% of U.S. physicians. In fiscal 2025, revenue was about $570.4 million, showing that its clinician audience and enterprise outreach convert into paid demand. PR and thought leadership help keep trust high with healthcare buyers.
| Metric | FY2025 |
|---|---|
| Revenue | $570.4M |
| Physician reach | 80%+ |
Price
$0 clinician access
Doximity gives clinicians free core access, and that freemium setup helps it reach about 80% of U.S. physicians while keeping engagement high. In fiscal 2025, Company Name reported $570.4 million in revenue, showing how free access feeds a larger network model that monetizes ads, workflow tools, and hiring. Free entry lowers friction, so more clinicians join and stay active.
Custom enterprise contracts
Doximity, Inc. sells enterprise access through negotiated contracts for pharma and healthcare clients, so price changes by product, audience, and campaign scope. That flexibility helps Doximity scale with demand; in fiscal 2025, revenue reached about $570.4 million. It also supports premium pricing where targeted reach and workflow tools matter most.
Subscription revenue model
Doximity’s price model rests on subscription-based enterprise deals for digital tools and marketing solutions, sold to pharma and healthcare clients. The platform says it reaches over 80% of U.S. physicians, which helps support repeat buying and pricing power. That subscription base gives Doximity recurring revenue visibility, and fiscal 2025 revenue grew at a strong double-digit pace.
Advertising-based pricing
Doximity, Inc. prices ads and sponsored digital engagement around clinician reach, targeting, and campaign volume, so buyers pay for access to a large, verified medical audience. Doximity says its network covers more than 80% of U.S. physicians, which helps support premium pricing tied to audience value. In FY2025, Doximity reported about $570 million in revenue, up 19% year over year.
Pricing tracks reach and targeting
Sponsored engagement adds monetization
Physician access supports premium value
No public list price
Doximity does not publish a consumer-style price list; enterprise pricing is custom by customer, module, and seat volume, which is standard for B2B healthcare software. That model fits a business that reported $475.6 million in fiscal 2024 revenue, with pricing shaped by workflow tools, recruiting, and marketing needs.
- Custom pricing, not public list rates
- Sold to health systems and pharma teams
- Revenue scale supports enterprise contracts
Doximity’s Custom Pricing Powers 19% FY2025 Revenue Growth
Doximity’s pricing is custom and enterprise-based, not public list pricing, so pharma, health system, and recruiting buyers pay by module, reach, and volume. That lets Company Name price against verified physician access, which covers over 80% of U.S. physicians. FY2025 revenue was $570.4 million, up 19% year over year.
| Price signal | FY2025 data |
|---|---|
| Pricing model | Custom enterprise contracts |
| Revenue | $570.4 million |
| Growth | 19% YoY |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.